[De-escalation strategies in differentiated thyroid cancer]

Area of Science:

• Oncology
• Endocrinology

Background:

• Thyroid cancer management has historically involved aggressive treatments.
• Prognostic algorithms and risk stratification are increasingly important.

Purpose of the Study:

• To outline the evolution of thyroid cancer treatment towards personalized medicine.
• To highlight de-escalation strategies in treatment and follow-up for improved patient outcomes.

Main Methods:

• Review of current and emerging strategies in thyroid cancer management.
• Application of prognostic algorithms for tailored treatment and follow-up.
• Integration of molecular therapies for advanced disease.

Main Results:

• Active surveillance for small papillary thyroid carcinomas avoids unnecessary interventions.
• Thyroid lobectomy is replacing total thyroidectomy for low-risk cancers.
• Treatment de-escalation (e.g., selective neck dissection, risk-adapted radioactive iodine therapy) is effective.
• Molecular therapies offer new options for aggressive, metastatic thyroid cancer.

Conclusions:

• Personalized approaches and de-escalation in thyroid cancer care minimize overtreatment.
• These strategies enhance patient quality of life while maintaining effective disease management.
• Molecular therapies represent a significant advancement for advanced thyroid cancer cases.